MedTrace Logo

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

NCT03686566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2024-02-28

No results posted yet for this study

Summary

To explore metabolic phenotypes of children with extra-cranial solid tumors and compare these with their histopathological and genetic alterations to discover potential novel biomarkers and therapeutic targets to improve outcomes in children with high risk disease.

Conditions

Interventions

DRUG

13C-glucose

Includes standard pre-operation nursing care, 13C-glucose infusion and finger stick/IV glucose checks and storage of blood sample approximately every 30 minutes

OTHER

No glucose infusion

Only includes standard pre-operation nursing care

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Tanya Watt, MD · UTSW

Eligibility

Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-16
Primary Completion
2024-01-02
Completion
2024-01-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686566 on ClinicalTrials.gov